FDA tells GLP-1 makers to warn of potential vision loss side effect
By Daniel Wu
The agency is requiring GLP-1 manufacturers to warn the drugs can increase risk of “eye stroke.”
This story was published by The Washington Post. Read the full article on their site.
Read the full story at washingtonpost.com(opens in a new tab)






